Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

New data presented at the 2025 World Congress of Pediatric Dermatology annual meeting highlights the efficacy and safety of ...

Icotrokinra appears to be an effective treatment for adolescent patients with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

Psoriasis shows on the skin, but it's a disease which goes a lot deeper and is linked to serious health problems. In recent years, newer targeted drugs are making a difference.

New results from a subgroup analysis of the ICONIC-LEAD study showed icotrokinra was effective and safe for the treatment of moderate to severe plaque psoriasis in adolescents, according to a press ...

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

Managing psoriasis is more than going to your doctor's appointments. Learn from experts on how to improve your self-care.

Additionally, some infections may exacerbate or trigger psoriasis, such as strep throat ... options if chlorine doesn’t aggravate your skin. Walking during the morning or evening hours ...

If your cholesterol levels are high, it can cause symptoms on your face, including yellowish patches or bumps on the ...

which enrolled adults and adolescents 12 years of age and older with moderate to severe plaque psoriasis. Top-line results show that 64.7% of patients achieved clear or almost clear skin measured ...